TENX Earnings Tenax Therapeutics, Inc.
Reported diluted EPS by fiscal period (SEC EDGAR). Chart & overview →
1–20 of 20
| Q1 2026 | 2026-03-31 | -0.35 | 2026-05-12 | 10-Q |
| FY 2025 | 2025-12-31 | -1.34 | 2026-03-10 | 10-K |
| Q3 2025 | 2025-09-30 | -0.96 | 2025-11-12 | 10-Q |
| Q2 2025 | 2025-06-30 | -0.56 | 2025-08-13 | 10-Q |
| Q1 2026 | 2025-03-31 | -0.28 | 2026-05-12 | 10-Q |
| FY 2025 | 2024-12-31 | -1.15 | 2026-03-10 | 10-K |
| Q3 2025 | 2024-09-30 | -1.37 | 2025-11-12 | 10-Q |
| Q2 2025 | 2024-06-30 | -4.65 | 2025-08-13 | 10-Q |
| Q1 2025 | 2024-03-31 | -3.12 | 2025-05-14 | 10-Q |
| FY 2024 | 2023-12-31 | -31.04 | 2025-03-25 | 10-K |
| Q3 2015 | 2015-01-31 | -0.32 | 2015-03-17 | 10-Q |
| Q2 2015 | 2014-10-31 | -0.22 | 2014-12-15 | 10-Q |
| Q1 2015 | 2014-07-31 | -0.08 | 2014-09-15 | 10-Q |
| FY 2014 | 2014-04-30 | -2.71 | 2014-07-29 | 10-K |
| Q3 2015 | 2014-01-31 | -2.58 | 2015-03-17 | 10-Q |
| Q2 2015 | 2013-10-31 | -2.96 | 2014-12-15 | 10-Q |
| Q1 2015 | 2013-07-31 | -3.36 | 2014-09-15 | 10-Q |
| FY 2014 | 2013-04-30 | -6.68 | 2014-07-29 | 10-K |
| Q3 2014 | 2013-01-31 | -5.91 | 2014-03-17 | 10-Q |
| Q2 2014 | 2012-10-31 | -4.85 | 2013-12-17 | 10-Q |
Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Informational only — not financial advice.